Mirae Asset Global Investments Co. Ltd. Has $3.40 Million Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 7.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 52,231 shares of the company’s stock after purchasing an additional 3,738 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned 0.09% of Azenta worth $3,402,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Macquarie Group Ltd. bought a new stake in shares of Azenta during the 2nd quarter worth approximately $160,068,000. State Street Corp bought a new stake in Azenta during the second quarter worth $141,290,000. JPMorgan Chase & Co. boosted its holdings in shares of Azenta by 115.1% in the 1st quarter. JPMorgan Chase & Co. now owns 3,018,907 shares of the company’s stock valued at $134,703,000 after purchasing an additional 1,615,328 shares in the last quarter. Norges Bank bought a new position in shares of Azenta in the 4th quarter valued at $88,297,000. Finally, Millennium Management LLC raised its holdings in shares of Azenta by 1,243.9% during the 4th quarter. Millennium Management LLC now owns 983,429 shares of the company’s stock worth $57,255,000 after buying an additional 910,250 shares in the last quarter. Institutional investors own 99.08% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Evercore ISI decreased their target price on Azenta from $64.00 to $60.00 and set an “in-line” rating on the stock in a research report on Thursday, April 4th. B. Riley upped their price objective on shares of Azenta from $61.00 to $79.00 and gave the stock a “buy” rating in a research report on Thursday, February 1st. Needham & Company LLC restated a “buy” rating and issued a $75.00 target price on shares of Azenta in a research report on Monday, April 8th. Jefferies Financial Group started coverage on shares of Azenta in a report on Thursday, April 4th. They set a “hold” rating and a $64.00 price target for the company. Finally, Stephens reissued an “equal weight” rating and set a $70.00 price objective on shares of Azenta in a report on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Azenta currently has an average rating of “Hold” and an average price target of $69.60.

Azenta Stock Performance

Shares of NASDAQ:AZTA opened at $51.17 on Thursday. The firm has a market cap of $2.85 billion, a PE ratio of -165.06 and a beta of 1.53. The firm’s fifty day moving average is $61.24 and its 200-day moving average is $58.97. Azenta, Inc. has a 52 week low of $36.01 and a 52 week high of $69.16.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $0.02 earnings per share for the quarter. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. The firm had revenue of $154.32 million during the quarter, compared to the consensus estimate of $151.86 million. Sell-side analysts forecast that Azenta, Inc. will post 0.27 EPS for the current year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.